v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating activities    
Net loss attributable to ordinary shareholders $ (2,079) $ (2,726)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 418 234
Depreciation and amortization 1 3
Realized gain on other investments (35)
Interest and gain on redemption of Series A-1 Preferred Shares (47)
Interest and gain on redemption of loan receivable (41)
SurancePlus fee income (1) (312)
Change in fair value of equity securities 40 260
Change in fair value of other investments 20 2,145
Income attributable to non-controlling interests 2 139
Change in operating assets and liabilities:    
Operating right-of-use asset 105
Operating lease liability (105)
Premiums receivable 293 (82)
Due from related parties 63
Deferred policy acquisition costs 7 (8)
Prepayment and other assets (56) 2
Losses payable 73
Reserve for loss and loss adjustment expenses 91
Unearned premiums reserve (65) 76
Accounts payable and other liabilities (57) 10
Net cash used in operating activities (1,348) (284)
Investing activities    
Proceeds of loan receivable 141
Proceeds on redemption of Series A-1 preferred stock 332
Proceeds from sale of equity securities 73 307
Proceeds from sale of other investments 63
Purchase of property and equipment (16)
Net cash provided by investing activities 120 780
Financing activities    
Net proceeds from issuance of ordinary shares 3,525 1,131
Tokenholders (1,214) (948)
Net proceeds from the issuance of tokens 1,469
Net cash provided by financing activities 2,311 1,652
Cash and cash equivalents, and restricted cash and cash equivalents:    
Net change during the year 1,083 2,148
Balance at beginning of year 5,893 3,745
Balance at end of year 6,976 5,893
Non-cash investing activities    
Reclassification of contributed non-controlling interest 105 23
Right-of-use lease asset obtained in exchange for operating lease liabilities $ 148